• Home
  • BVR and IP Valuation
  • IP Value Products
  • Your Account
    • Checkout
  • ktMine
  • Free IP Value Wire
  • Contact BVR
RSS Subscribe RSS

BVR's IP Management & Valuation Wire

News and best practices on valuing intellectual property

IP business time frames are now divided into Before Nortel and After Nortel

Written by Randy on October 25, 2011 - 0 Comments
Categories: intellectual property M&A, investing in IP, ip monetization, IP valuation research, IP value comparables & research, Patents

Joff Wild attended the Nortel session at the annual LES USA and Canada meeting and walked away with two distinct impressions: Without early and detailed input of IP management and valuation advisors, the Nortel auction probably would never have occurred. Education about the value of IP was necessary on both the buy and sell sides [...]

Read more »

Share your thoughts...

PWC releases report on 2011 patent litigation, contrasts reasonable royalty rates with lost profits

Written by Randy on October 24, 2011 - 0 Comments
Categories: commercial litigation, damages, damages and lost profits valuations, ip monetization, IP valuation research, IP value comparables & research, Patent Litigation, Patents, royalties-reasonable

A new PWC study shows reasonable royalties are the most frequent kind of damages awards in patent cases and comprise a greater share with each passing year, while seeking recovery of lost profits can be costly and complex. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe to the comments on [...]

Read more »

Share your thoughts...

Google’s own email and court filing hints at willful infringement of Oracle patents

Written by Randy on October 24, 2011 - 0 Comments
Categories: best practices, case law analysis, commercial litigation, damages, licensing, Patent Litigation, Patents, software patent

IPBlog has reported on the infamous, incriminating Google email. Now a US judge has allowed Oracle to use the internal Google email in its Java patent infringement lawsuit against Android. The email includes text from a Google engineer suggesting that the company had no choice but to negotiate a license for using Java in Android. [...]

Read more »

Share your thoughts...

New patent law removes the teeth behind disclosure of “best mode”

Written by Randy on October 24, 2011 - 0 Comments
Categories: best practices, IP valuation research, legislation, Patents, policy

The America Invents Act changes the bargain created in the nineteenth century when Congress granted inventors a limited monopoly on their invention in exchange for revealing to the world how it works in its “best mode.” According  to Jake Holdreth and Joseph Hosteny, writing in Corporate Counsel, the compromise presented in AIA creates “confusion and [...]

Read more »

Share your thoughts...

Inventors advised to think twice before patenting

Written by Randy on October 21, 2011 - 0 Comments
Categories: best practices, early stage IP, ip monetization, licensing, Patents, Trade Secrets

Michael Hess’s advice to individual inventors suffices as a checklist for organizations considering keeping an invention under wraps under trade secrets protection vs. filing for a patent. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe to the comments on this post

Read more »

Share your thoughts...

Will Amazon Buy Palm IP?

Written by Randy on October 21, 2011 - 0 Comments
Categories: financial reporting for IP, intellectual property M&A, IP valuation research, Patents, purchase price allocation

Amazon launched their new tablet, the Fire, and was immediately sued for patent infringement by Smartphone Technologies, a subsidiary of Acacia, which has rights to several Palm patents. Analysts believe in order for Amazon to join the mobile wars, they have to join the patent wars, too. So the speculation is, to protect Fire, will [...]

Read more »

Share your thoughts...

Advice offered to pharma and biotech on reducing their in-licensing royalty costs

Written by Randy on October 20, 2011 - 0 Comments
Categories: best practices, IP valuation research, licensing, Patents, royalty

Typically a biotech or pharmaceutical company will need to license another’s inventions in order to manufacture their own products. Lori M. Waldron of Sills, Cummins & Gross PC, writing in National Law Review, offered some tips on how to minimize these costs. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe [...]

Read more »

Share your thoughts...

Myriad likely to be appealed by plaintiffs

Written by Randy on October 20, 2011 - 1 Comment
Categories: commercial litigation, IP valuation research, Patent Litigation, Patents

In a not-unexpected move, the American Civil Liberties Union and the Public Patent Foundation said last week they will beat the December deadline and petition the Supreme Court to overturn a CAFC decision and rule that Salt Lake City-based Myriad Genetics cannot hold patents on human genes. Bookmark on DeliciousDigg this postRecommend on Facebookshare via [...]

Read more »

1 Comment

Proposed legislation would create a federal civil cause of action for trade secrets misappropriation

Written by Randy on October 19, 2011 - 0 Comments
Categories: legislation, policy, Trade Secrets

A pair of amendments to the Currency Exchange Rate Oversight Reform Act of 2011were proposed early this month by Senators Chris Coons (D-NJ) and Herb Kohl (D-WI). The bill would allow US businesses allegedly wronged by trade-secret theft to sue in federal court by streamlining existing state laws into a uniform national statute and would [...]

Read more »

Share your thoughts...

A patent cliff doesn’t just affect pharma and biotech, tech transfer must plan for it as well

Written by Randy on October 19, 2011 - 2 Comments
Categories: best practices, early stage IP, investing in IP, ip monetization, licensing, Patents, royalty, technology transfer

The University of Minnesota’s will see a huge reduction in royalty revenue as patents on their blockbuster HIV drug expire. Ziagen, which prevents the HIV virus from reproducing, has made the University and inventor Robert Vince a combined $524 million since 1999. Bookmark on DeliciousDigg this postRecommend on Facebookshare via RedditShare with StumblersTweet about itSubscribe [...]

Read more »

2 Comments

« Previous Page — Next Page »

  • Recent Posts

    • U.S. Court of Appeals for the Federal Circuit recognizes royalty damages as a remedy in a copyright case
    • Twitter’s creative approach to IP ownership has its critics
    • IP values are the “time bombs” of the future
    • Can the purchase price allocation process be used to bring order to the spiraling “value” of IP?
    • Court of Appeals calls into question the ability of the Economic Espionage Act to protect trade secrets
  • Blogroll

    • Ian McClure’s IP Prospective
    • Intellectual Property Watch
    • Interdisciplinary patents from Glenn Foster
    • IP Think Tank’s Think IP Strategy
    • IPCloseUp
    • IPLawAlert
    • IPMetrics blog
    • Law 360’s Intellectual Property Law
    • Mike Moberly's Business IP blog
    • Mission Intangible!
    • Patently-O
  • Enter your email address:

  • Categories

    • best practices
    • brand value
    • case law analysis
    • CLE
    • commercial litigation
    • copyright values
    • CPE opportunities
    • damages
    • damages and lost profits valuations
    • design
    • early stage IP
    • expert witness
    • financial reporting for IP
    • infringement lawsuits
    • intangible property
    • intellectual property M&A
    • investing in IP
    • ip monetization
    • IP ownership
    • IP strategy
    • IP valuation research
    • IP value comparables & research
    • ITC
    • legislation
    • licensing
    • Patent Litigation
    • Patents
    • policy
    • purchase price allocation
    • reputation
    • royalties-reasonable
    • royalty
    • software patent
    • technology transfer
    • trade dress
    • Trade Secrets
    • trademark
    • trademark infringement
    • transfer pricing
    • Uncategorized
    • United States Patent and Trademark Office
    • USPTO
  • Blogroll

    • Ian McClure’s IP Prospective
    • Intellectual Property Watch
    • Interdisciplinary patents from Glenn Foster
    • IP Think Tank’s Think IP Strategy
    • IPCloseUp
    • IPLawAlert
    • IPMetrics blog
    • Law 360’s Intellectual Property Law
    • Mike Moberly's Business IP blog
    • Mission Intangible!
    • Patently-O

Admin Login

Powered by frugal


Copyright © 2012 BVR's IP Management & Valuation Wire